{"database": "openregs", "table": "documents", "rows": [["FDA-2013-N-1525-0207", "FDA", "FDA-2013-N-1525", "Cited Reference Martin-Moreno et al Prolonged Oral Cannabinoid Administration Prevents Neuroinflammation, Lowers b-amyloid\nLevels and Improves Cognitive Performance in Tg APP 2576 Mice RE: Request for Nomination from Gary Gray Pharmacist dba COMPLEX", "Supporting & Related Material", "Background Material", "2014-10-17T04:00:00Z", 2014, 10, null, null, "2015-03-23T19:51:17Z", null, 0, 0, "09000064818ad191"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-N-1525-0207"], "units": {}, "query_ms": 35.60070402454585, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}